CD34 and myocardial infarction: The importance of the vascular niche in preclinical cases of stem cell therapy has also been shown in our previous articles where the beneficial effects of CD34+ progenitor cells or endothelial progenitor cells (EPCs) after MI on cardiac repair were magnified in the swine with autologous preexisting angiogenesis [4, 9].